Investors & Shareholders |
|
|
|
For more information of current investors and shareholders see below. |
|
Read more...
|
|
ProKyma Scaling Up |
|
|
|
ProKyma completed a Series A investment round in December 07. Since then it has been working on scaling up the application for microbiological testing and improving the reliability of immunoassays. |
|
Read more...
|
|
MoD Spin Out |
|
|
|
MoD SPIN-OUT RECEIVES £470K FUNDING FOR TECHNOLOGY THAT PROMISES EARLIER DETECTION OF DISEASE ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl), today announced a £470K funding round led by Merseyside Special Investment Fund’s Liverpool Seed Fund. The National Endowment for Science, Technology and the Arts (NESTA), Rainbow Seed Fund and ProKyma management also participated in the round. |
|
Read more...
|
|
Investor Relations |
|
|
|
ProKyma Technologies is a spin-out company from the Defence Science and Technology Laboratory (Dstl).
Ploughshare Innovations, Dstl’s technology transfer company, was responsible for ProKyma’s formation in 2006 following a market evaluation supported by the Central Science Laboratory (CSL) and the Veterinary Laboratories Agency (VLA). Along with management these were the founding shareholders.
|
|
Read more...
|
|
Scientific Advisory Teams |
|
|
Dr Martin McDonnell – Dstl
Dr Martin McDonnell is a Principal Scientist in the Detection Department of the Defence Science Technology Laboratory at Porton Down, Wiltshire in the United Kingdom. He received a first class honours degree and PhD in chemistry from the University of Newcastle Upon Tyne in 1984. Following postdoctoral research positions at the Australian National University, Southampton University and University College London, he joined what was then the Chemical and Biological Defence Establishment in 1992. Since that time he has worked on the rapid detection and identification of pathogenic micro-organisms. |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 9 of 15 |
